What is Accustem Sciences Inc?
, a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 4.50M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.